Pathology Handbook

New search

Alternative Names:

AMH
Mullerian Inhibiting Substance
Mullerian Inhibiting Factor

Laboratory:

Clinical Biochemistry

Test Code:

AMH

Specimen Types:

Blood

Container Types:

SST

Adults Volume or Mass:

2 mL

Minimum/Paediatric Volume or Mass:

1 mL

Collection & Request Instructions:

Please note test not covered by Medicare. Patient will be required to cover cost ($66 plus transport

Patient consent form must be signed and sent with sample.

If a consent form is signed there is no need for Pathologist approval.

If test is for an inpatient, no consent form is required - Pathologist approval required.

Transport Instructions between Sites and/or Laboratories:

On Ice

Assay Frequency:

Weekly

External Laboratory:

Monash Pathology

Additional Notes:

Must be approved by a Chemical Pathologist

Comments

AMH is an objective measure of ovarian reserve and response to ovulation induction treatment. A graph

to assist interpretation is available from the Monash Pathology.

An AMH of 35-45 pmol/L indicates optimal fertility; 15-30 satisfactory fertility; 2-15 Low fertility;

0-2 Very low fertility; and >50 consistent with PCOS.

AMH may be useful to monitor AMH secreting granulosa cell tumours of the ovary in post-menopausal or

ovarectomised women where levels should be <1 pmol/L. In cycling women, samples should be collected on

Day 2-5 of the menstrual cycle and followed over time.

From 23 Feb 2023 - AMH is performed by Monash Pathology on the Beckman DxI platform.

Age Related Reference Interval: Refer to report.